Quantification of TUNEL-positive tumor cells revealed a significantly higher percentage of apoptotic cells in the TRAIL-ATNCIL4rP treatment group (73.2%) compared with the TRAIL treatment group (32.1%) (Fig. 6E). Here, TNFSF10 is linked to neoplasm.